DETAILED ACTION
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Applicants’ Amendment
1) Acknowledgment is made of Applicants’ amendment filed 08/13//26 in response to the non-final Office Action mailed 05/13/26.
Status of Claims
2) Claims 10-14 and 17-24 have been canceled via the amendment filed 08/13/2026.
Claim 9 has been amended via the amendment filed 08/13/2026.
Claims 9, 15 and 16 are pending and are under examination.
Attempt at Facilitating an Examiner’s Amendment
3) In the interest of compact prosecution and to advance prosecution of this application towards a potential Examiner’s amendment and allowance, Applicants’ representative Mr. Yue “Robert” Xu was contacted telephonically by the Office. The allowable subject matter and the acceptable claim language were conveyed. A voice mail message was left to Applicants’ representative at the telephone number provided, (408) 647-5296 requesting him to contact the Examiner of record. See Interview Summary. The Examiner has not heard from Applicants’ representative within the indicated deadline and as of the issuance of this Office Action.
Prior Citation of Title 35 Sections
4) The text of those sections of Title 35 U.S. Code not included in this action can be found in a prior Office Action.
Prior Citation of References
5) The references cited or used as prior art in support of one or more rejections in the instant Office Action and not included on an attached form PTO-892 or form PTO-1449 have been previously cited and made of record.
Priority Application
6) Acknowledgment is made of Applicants’ filing on 08/13/26 of a copy of the certified English translation of the foreign priority application 202110415247.X filed 04/18/2021 in China.
Objection(s) Withdrawn
7) The objections to the specification set forth in paragraph 8 of the Office Action mailed 08/13/26 are withdrawn in light of Applicants’ amendments thereto.
Rejection(s) Moot
8) The rejection of claim 10 set forth in paragraph 10 of the Office Action mailed 05/13/26 under 35 U.S.C § 35 U.S.C § 102(a)(1) and 35 U.S.C § 102(a)(2) as being anticipated by US 20070280999 A1 (US ‘999, of record) is moot in light of Applicants’ cancellation of the claim.
Rejection(s) Withdrawn
9) The rejection of claims 9, 15 and 16 set forth in paragraph 10 of the Office Action mailed 05/13/26 under 35 U.S.C § 35 U.S.C § 102(a)(1) and 35 U.S.C § 102(a)(2) as being anticipated by US 20070280999 A1 (US ‘999, of record) is withdrawn in light of Applicants’ claim amendments and arguments.
Applicants acknowledge that US ‘999 discloses an orally administrable composition for the photoprotection of the skin comprising at least one probiotic lactic acid bacterium. Applicants concede that the preamble phrase "for delaying skin aging" is nonlimiting. Applicants in essence contend that US '999 provides a broad list of potential probiotic bacteria that may be selected, including the species Lactobacillus reuteri, but does not identify, deposit, characterize, or exemplify a Lactobacillus reuteri strain. Applicants state that US '999 is devoid of any disclosure regarding deposit numbers, origins, genetic sequences, Riboprinter fingerprints, RAPD fingerprints, rep-PCR fingerprints, 16S rDNA sequences, or experimental examples related to any Lactobacillus reuteri strain. Applicants refer to MPEP § 2131.02 and state that a disclosure of a genus or a broad list only anticipates a claimed species if the specific species is clearly named or can be "at once envisaged". Applicants argue that the mere inclusion of the broad species name Lactobacillus reuteri in a generic list of candidates in US '999 does not allow a person of ordinary skill in the art to immediately envisage the specific deposited strain CCTCC NO: M2021153 and therefore, the generic disclosure of the species in US '999 cannot be equated to a disclosure of the specific deposited strain of the present application. Applicants assert that US '999 does not provide data or technical reasoning establishing that an unidentified Lactobacillus reuteri strain necessarily possesses the claimed skin anti-aging effects. Applicants state that US '999 does not inherently disclose CCTCC M2021153 or its anti-aging effects. Applicants assert that US '999 merely lists Lactobacillus reuteri as a candidate but never actually demonstrates that this species independently possesses the claimed anti-aging functions.
Rejection(s) under 35 U.S.C § 112(b) or (Pre-AIA ), Second paragraph
10) The following is a quotation of 35 U.S.C § 112(b):
(B) CONCLUSION.--The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C § 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
11) Claims 9, 15 and 16 are rejected under 35 U.S.C § 112(b) or 35 U.S.C § 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which inventor or a joint inventor, or for the pre-AIA the Applicant regards as the invention.
(a) Claim 9, as amended, is ambiguous and indefinite in the recitation: “administering a strain of Lactobacillus reuteri”, because it is unclear to whom or what subject the recited Lactobacillus reuteri is administered to.
(b) Claims 15 and 16, which depend from claim 9, are also rejected as being indefinite because of the indefiniteness identified in the base claim.
Relevant Art
12) The art made of record and not relied upon in any of the rejections is considered pertinent to Applicants’ disclosure. The following are the disclosures of Limisilactobacillus reuteri strains comprising a nucleotide sequence that comprises therein the nucleotide sequence of Applicants’ SEQ ID NO: 1.
(A)
MT510519/c
LOCUS MT510519 1483 bp DNA linear BCT 31-MAY-2020
DEFINITION Limosilactobacillus reuteri strain 6111 16S ribosomal RNA gene,
partial sequence.
ACCESSION MT510519
VERSION MT510519.1
SOURCE Limosilactobacillus reuteri
ORGANISM Limosilactobacillus reuteri
Bacteria; Bacillota; Bacilli; Lactobacillales; Lactobacillaceae;
Limosilactobacillus.
REFERENCE 1 (bases 1 to 1483)
AUTHORS Fang,S.
TITLE Direct Submission
JOURNAL Submitted (26-MAY-2020) R&D, Wuhan Wecare Probiotic Research
Institute Co., Ltd., No. 666 Gaoxin Avenue, Wuhan 430075, China
COMMENT Sequences were screened for chimeras by the submitter using Applied
Biosystems DNA sequencers.
##Assembly-Data-START##
Sequencing Technology :: Sanger dideoxy sequencing
##Assembly-Data-END##
FEATURES Location/Qualifiers
source 1..1483
/organism="Limosilactobacillus reuteri"
/mol_type="genomic DNA"
/strain="6111"
/db_xref="taxon:1598"
rRNA <1..>1483
/product="16S ribosomal RNA
Query Match 100%; Score 1428; Length 1483; Best Local Similarity 100%;
Matches 1428; Conservative 0; Mismatches 0; Indels 0; Gaps 0.
Qy 1 AAAGGTTAGGCCACCGACTTTGGGCGTTACAAACTCCCATGGTGTGACGGGCGGTGTGTA 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1451 AAAGGTTAGGCCACCGACTTTGGGCGTTACAAACTCCCATGGTGTGACGGGCGGTGTGTA 1392
Qy 61 CAAGGCCCGGGAACGTATTCACCGCGGCATGCTGATCCGCGATTACTAGCGATTCCGACT 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1391 CAAGGCCCGGGAACGTATTCACCGCGGCATGCTGATCCGCGATTACTAGCGATTCCGACT 1332
Qy 121 TCGTGTAGGCGAGTTGCAGCCTACAGTCCGAACTGAGAACGGCTTTAAGAGATTAGCTTA 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1331 TCGTGTAGGCGAGTTGCAGCCTACAGTCCGAACTGAGAACGGCTTTAAGAGATTAGCTTA 1272
Qy 181 CTCTCGCGAGTTTGCGACTCGTTGTACCGTCCATTGTAGCACGTGTGTAGCCCAGGTCAT 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1271 CTCTCGCGAGTTTGCGACTCGTTGTACCGTCCATTGTAGCACGTGTGTAGCCCAGGTCAT 1212
Qy 241 AAGGGGCATGATGATCTGACGTCGTCCCCACCTTCCTCCGGTTTGTCACCGGCAGTCTCA 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1211 AAGGGGCATGATGATCTGACGTCGTCCCCACCTTCCTCCGGTTTGTCACCGGCAGTCTCA 1152
Qy 301 CTAGAGTGCCCAACTCAATGCTGGCAACTAGTAACAAGGGTTGCGCTCGTTGCGGGACTT 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1151 CTAGAGTGCCCAACTCAATGCTGGCAACTAGTAACAAGGGTTGCGCTCGTTGCGGGACTT 1092
Qy 361 AACCCAACATCTCACGACACGAGCTGACGACGACCATGCACCACCTGTCATTGCGTCCCC 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1091 AACCCAACATCTCACGACACGAGCTGACGACGACCATGCACCACCTGTCATTGCGTCCCC 1032
Qy 421 GAAGGGAACGCCTTATCTCTAAGGTTAGCGCAAGATGTCAAGACCTGGTAAGGTTCTTCG 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1031 GAAGGGAACGCCTTATCTCTAAGGTTAGCGCAAGATGTCAAGACCTGGTAAGGTTCTTCG 972
Qy 481 CGTAGCTTCGAATTAAACCACATGCTCCACCGCTTGTGCGGGCCCCCGTCAATTCCTTTG 540
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 971 CGTAGCTTCGAATTAAACCACATGCTCCACCGCTTGTGCGGGCCCCCGTCAATTCCTTTG 912
Qy 541 AGTTTCAACCTTGCGGTCGTACTCCCCAGGCGGAGTGCTTAATGCGTTAGCTCCGGCACT 600
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 911 AGTTTCAACCTTGCGGTCGTACTCCCCAGGCGGAGTGCTTAATGCGTTAGCTCCGGCACT 852
Qy 601 GAAGGGCGGAAACCCTCCAACACCTAGCACTCATCGTTTACGGCATGGACTACCAGGGTA 660
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 851 GAAGGGCGGAAACCCTCCAACACCTAGCACTCATCGTTTACGGCATGGACTACCAGGGTA 792
Qy 661 TCTAATCCTGTTCGCTACCCATGCTTTCGAGCCTCAGCGTCAGTTGCAGACCAGACAGCC 720
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 791 TCTAATCCTGTTCGCTACCCATGCTTTCGAGCCTCAGCGTCAGTTGCAGACCAGACAGCC 732
Qy 721 GCCTTCGCCACTGGTGTTCTTCCATATATCTACGCATTCCACCGCTACACATGGAGTTCC 780
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 731 GCCTTCGCCACTGGTGTTCTTCCATATATCTACGCATTCCACCGCTACACATGGAGTTCC 672
Qy 781 ACTGTCCTCTTCTGCACTCAAGTCGCCCGGTTTCCGATGCACTTCTTCGGTTAAGCCGAA 840
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 671 ACTGTCCTCTTCTGCACTCAAGTCGCCCGGTTTCCGATGCACTTCTTCGGTTAAGCCGAA 612
Qy 841 GGCTTTCACATCAGACCTAAGCAACCGCCTGCGCTCGCTTTACGCCCAATAAATCCGGAT 900
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 611 GGCTTTCACATCAGACCTAAGCAACCGCCTGCGCTCGCTTTACGCCCAATAAATCCGGAT 552
Qy 901 AACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGTGACTTTCTGG 960
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 551 AACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGTGACTTTCTGG 492
Qy 961 TTGGATACCGTCACTGCGTGAACAGTTACTCTCACGCACGTTCTTCTCCAACAACAGAGC 1020
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 491 TTGGATACCGTCACTGCGTGAACAGTTACTCTCACGCACGTTCTTCTCCAACAACAGAGC 432
Qy 1021 TTTACGAGCCGAAACCCTTCTTCACTCACGCGGTGTTGCTCCATCAGGCTTGCGCCCATT 1080
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 431 TTTACGAGCCGAAACCCTTCTTCACTCACGCGGTGTTGCTCCATCAGGCTTGCGCCCATT 372
Qy 1081 GTGGAAGATTCCCTACTGCTGCCTCCCGTAGGAGTATGGACCGTGTCTCAGTTCCATTGT 1140
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 371 GTGGAAGATTCCCTACTGCTGCCTCCCGTAGGAGTATGGACCGTGTCTCAGTTCCATTGT 312
Qy 1141 GGCCGATCAGTCTCTCAACTCGGCTATGCATCATCGCCTTGGTAAGCCGTTACCTTACCA 1200
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 311 GGCCGATCAGTCTCTCAACTCGGCTATGCATCATCGCCTTGGTAAGCCGTTACCTTACCA 252
Qy 1201 ACTAGCTAATGCACCGCAGGTCCATCCCAGAGTGATAGCCAAAGCCATCTTTCAAACAAA 1260
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 251 ACTAGCTAATGCACCGCAGGTCCATCCCAGAGTGATAGCCAAAGCCATCTTTCAAACAAA 192
Qy 1261 AGCCATGCGGCTTTTGTTGTTATGCGGTATTAGCATCTGTTTCCAAATGTTATCCCCCGC 1320
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 191 AGCCATGCGGCTTTTGTTGTTATGCGGTATTAGCATCTGTTTCCAAATGTTATCCCCCGC 132
Qy 1321 TCCGGGGCAGGTTACCTACGTGTTACTCACCCGTCCGCCACTCACTGGTGATCCATCGTC 1380
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 131 TCCGGGGCAGGTTACCTACGTGTTACTCACCCGTCCGCCACTCACTGGTGATCCATCGTC 72
Qy 1381 AATCAGGTGCAAGCACCATCAATCAGTTGGGCCAGTGCGTACGACTGC 1428
||||||||||||||||||||||||||||||||||||||||||||||||
Db 71 AATCAGGTGCAAGCACCATCAATCAGTTGGGCCAGTGCGTACGACTGC 24
(B)
MT510518/c
LOCUS MT510518 1484 bp DNA linear BCT 31-MAY-2020
DEFINITION Limosilactobacillus reuteri strain 6110 16S ribosomal RNA gene,
partial sequence.
ACCESSION MT510518
VERSION MT510518.1
SOURCE Limosilactobacillus reuteri
ORGANISM Limosilactobacillus reuteri
Bacteria; Bacillota; Bacilli; Lactobacillales; Lactobacillaceae;
Limosilactobacillus.
REFERENCE 1 (bases 1 to 1484)
AUTHORS Fang,S.
TITLE Direct Submission
JOURNAL Submitted (26-MAY-2020) R&D, Wuhan Wecare Probiotic Research
Institute Co., Ltd., No. 666 Gaoxin Avenue, Wuhan 430075, China
COMMENT Sequences were screened for chimeras by the submitter using Applied
Biosystems DNA sequencers.
##Assembly-Data-START##
Sequencing Technology :: Sanger dideoxy sequencing
##Assembly-Data-END##
FEATURES Location/Qualifiers
source 1..1484
/organism="Limosilactobacillus reuteri"
/mol_type="genomic DNA"
/strain="6110"
/db_xref="taxon:1598"
rRNA <1..>1484
/product="16S ribosomal RNA
Query Match 100%; Score 1428; Length 1484; Best Local Similarity 100%;
Matches 1428; Conservative 0; Mismatches 0; Indels 0; Gaps 0.
Qy 1 AAAGGTTAGGCCACCGACTTTGGGCGTTACAAACTCCCATGGTGTGACGGGCGGTGTGTA 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1453 AAAGGTTAGGCCACCGACTTTGGGCGTTACAAACTCCCATGGTGTGACGGGCGGTGTGTA 1394
Qy 61 CAAGGCCCGGGAACGTATTCACCGCGGCATGCTGATCCGCGATTACTAGCGATTCCGACT 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1393 CAAGGCCCGGGAACGTATTCACCGCGGCATGCTGATCCGCGATTACTAGCGATTCCGACT 1334
Qy 121 TCGTGTAGGCGAGTTGCAGCCTACAGTCCGAACTGAGAACGGCTTTAAGAGATTAGCTTA 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1333 TCGTGTAGGCGAGTTGCAGCCTACAGTCCGAACTGAGAACGGCTTTAAGAGATTAGCTTA 1274
Qy 181 CTCTCGCGAGTTTGCGACTCGTTGTACCGTCCATTGTAGCACGTGTGTAGCCCAGGTCAT 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1273 CTCTCGCGAGTTTGCGACTCGTTGTACCGTCCATTGTAGCACGTGTGTAGCCCAGGTCAT 1214
Qy 241 AAGGGGCATGATGATCTGACGTCGTCCCCACCTTCCTCCGGTTTGTCACCGGCAGTCTCA 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1213 AAGGGGCATGATGATCTGACGTCGTCCCCACCTTCCTCCGGTTTGTCACCGGCAGTCTCA 1154
Qy 301 CTAGAGTGCCCAACTCAATGCTGGCAACTAGTAACAAGGGTTGCGCTCGTTGCGGGACTT 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1153 CTAGAGTGCCCAACTCAATGCTGGCAACTAGTAACAAGGGTTGCGCTCGTTGCGGGACTT 1094
Qy 361 AACCCAACATCTCACGACACGAGCTGACGACGACCATGCACCACCTGTCATTGCGTCCCC 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1093 AACCCAACATCTCACGACACGAGCTGACGACGACCATGCACCACCTGTCATTGCGTCCCC 1034
Qy 421 GAAGGGAACGCCTTATCTCTAAGGTTAGCGCAAGATGTCAAGACCTGGTAAGGTTCTTCG 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1033 GAAGGGAACGCCTTATCTCTAAGGTTAGCGCAAGATGTCAAGACCTGGTAAGGTTCTTCG 974
Qy 481 CGTAGCTTCGAATTAAACCACATGCTCCACCGCTTGTGCGGGCCCCCGTCAATTCCTTTG 540
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 973 CGTAGCTTCGAATTAAACCACATGCTCCACCGCTTGTGCGGGCCCCCGTCAATTCCTTTG 914
Qy 541 AGTTTCAACCTTGCGGTCGTACTCCCCAGGCGGAGTGCTTAATGCGTTAGCTCCGGCACT 600
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 913 AGTTTCAACCTTGCGGTCGTACTCCCCAGGCGGAGTGCTTAATGCGTTAGCTCCGGCACT 854
Qy 601 GAAGGGCGGAAACCCTCCAACACCTAGCACTCATCGTTTACGGCATGGACTACCAGGGTA 660
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 853 GAAGGGCGGAAACCCTCCAACACCTAGCACTCATCGTTTACGGCATGGACTACCAGGGTA 794
Qy 661 TCTAATCCTGTTCGCTACCCATGCTTTCGAGCCTCAGCGTCAGTTGCAGACCAGACAGCC 720
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 793 TCTAATCCTGTTCGCTACCCATGCTTTCGAGCCTCAGCGTCAGTTGCAGACCAGACAGCC 734
Qy 721 GCCTTCGCCACTGGTGTTCTTCCATATATCTACGCATTCCACCGCTACACATGGAGTTCC 780
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 733 GCCTTCGCCACTGGTGTTCTTCCATATATCTACGCATTCCACCGCTACACATGGAGTTCC 674
Qy 781 ACTGTCCTCTTCTGCACTCAAGTCGCCCGGTTTCCGATGCACTTCTTCGGTTAAGCCGAA 840
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 673 ACTGTCCTCTTCTGCACTCAAGTCGCCCGGTTTCCGATGCACTTCTTCGGTTAAGCCGAA 614
Qy 841 GGCTTTCACATCAGACCTAAGCAACCGCCTGCGCTCGCTTTACGCCCAATAAATCCGGAT 900
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 613 GGCTTTCACATCAGACCTAAGCAACCGCCTGCGCTCGCTTTACGCCCAATAAATCCGGAT 554
Qy 901 AACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGTGACTTTCTGG 960
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 553 AACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGTGACTTTCTGG 494
Qy 961 TTGGATACCGTCACTGCGTGAACAGTTACTCTCACGCACGTTCTTCTCCAACAACAGAGC 1020
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 493 TTGGATACCGTCACTGCGTGAACAGTTACTCTCACGCACGTTCTTCTCCAACAACAGAGC 434
Qy 1021 TTTACGAGCCGAAACCCTTCTTCACTCACGCGGTGTTGCTCCATCAGGCTTGCGCCCATT 1080
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 433 TTTACGAGCCGAAACCCTTCTTCACTCACGCGGTGTTGCTCCATCAGGCTTGCGCCCATT 374
Qy 1081 GTGGAAGATTCCCTACTGCTGCCTCCCGTAGGAGTATGGACCGTGTCTCAGTTCCATTGT 1140
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 373 GTGGAAGATTCCCTACTGCTGCCTCCCGTAGGAGTATGGACCGTGTCTCAGTTCCATTGT 314
Qy 1141 GGCCGATCAGTCTCTCAACTCGGCTATGCATCATCGCCTTGGTAAGCCGTTACCTTACCA 1200
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 313 GGCCGATCAGTCTCTCAACTCGGCTATGCATCATCGCCTTGGTAAGCCGTTACCTTACCA 254
Qy 1201 ACTAGCTAATGCACCGCAGGTCCATCCCAGAGTGATAGCCAAAGCCATCTTTCAAACAAA 1260
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 253 ACTAGCTAATGCACCGCAGGTCCATCCCAGAGTGATAGCCAAAGCCATCTTTCAAACAAA 194
Qy 1261 AGCCATGCGGCTTTTGTTGTTATGCGGTATTAGCATCTGTTTCCAAATGTTATCCCCCGC 1320
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 193 AGCCATGCGGCTTTTGTTGTTATGCGGTATTAGCATCTGTTTCCAAATGTTATCCCCCGC 134
Qy 1321 TCCGGGGCAGGTTACCTACGTGTTACTCACCCGTCCGCCACTCACTGGTGATCCATCGTC 1380
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 133 TCCGGGGCAGGTTACCTACGTGTTACTCACCCGTCCGCCACTCACTGGTGATCCATCGTC 74
Qy 1381 AATCAGGTGCAAGCACCATCAATCAGTTGGGCCAGTGCGTACGACTGC 1428
||||||||||||||||||||||||||||||||||||||||||||||||
Db 73 AATCAGGTGCAAGCACCATCAATCAGTTGGGCCAGTGCGTACGACTGC 26
(C)
MT510522/c
LOCUS MT510522 1488 bp DNA linear BCT 31-MAY-2020
DEFINITION Limosilactobacillus reuteri strain 6114 16S ribosomal RNA gene,
partial sequence.
ACCESSION MT510522
VERSION MT510522.1
SOURCE Limosilactobacillus reuteri
ORGANISM Limosilactobacillus reuteri
Bacteria; Bacillota; Bacilli; Lactobacillales; Lactobacillaceae;
Limosilactobacillus.
REFERENCE 1 (bases 1 to 1488)
AUTHORS Fang,S.
TITLE Direct Submission
JOURNAL Submitted (26-MAY-2020) R&D, Wuhan Wecare Probiotic Research
Institute Co., Ltd., No. 666 Gaoxin Avenue, Wuhan 430075, China
COMMENT Sequences were screened for chimeras by the submitter using Applied
Biosystems DNA sequencers.
##Assembly-Data-START##
Sequencing Technology :: Sanger dideoxy sequencing
##Assembly-Data-END##
FEATURES Location/Qualifiers
source 1..1488
/organism="Limosilactobacillus reuteri"
/mol_type="genomic DNA"
/strain="6114"
/db_xref="taxon:1598"
rRNA <1..>1488
/product="16S ribosomal RNA
Query Match 100%; Score 1428; Length 1488; Best Local Similarity 100%;
Matches 1428; Conservative 0; Mismatches 0; Indels 0; Gaps 0.
Qy 1 AAAGGTTAGGCCACCGACTTTGGGCGTTACAAACTCCCATGGTGTGACGGGCGGTGTGTA 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1454 AAAGGTTAGGCCACCGACTTTGGGCGTTACAAACTCCCATGGTGTGACGGGCGGTGTGTA 1395
Qy 61 CAAGGCCCGGGAACGTATTCACCGCGGCATGCTGATCCGCGATTACTAGCGATTCCGACT 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1394 CAAGGCCCGGGAACGTATTCACCGCGGCATGCTGATCCGCGATTACTAGCGATTCCGACT 1335
Qy 121 TCGTGTAGGCGAGTTGCAGCCTACAGTCCGAACTGAGAACGGCTTTAAGAGATTAGCTTA 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1334 TCGTGTAGGCGAGTTGCAGCCTACAGTCCGAACTGAGAACGGCTTTAAGAGATTAGCTTA 1275
Qy 181 CTCTCGCGAGTTTGCGACTCGTTGTACCGTCCATTGTAGCACGTGTGTAGCCCAGGTCAT 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1274 CTCTCGCGAGTTTGCGACTCGTTGTACCGTCCATTGTAGCACGTGTGTAGCCCAGGTCAT 1215
Qy 241 AAGGGGCATGATGATCTGACGTCGTCCCCACCTTCCTCCGGTTTGTCACCGGCAGTCTCA 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1214 AAGGGGCATGATGATCTGACGTCGTCCCCACCTTCCTCCGGTTTGTCACCGGCAGTCTCA 1155
Qy 301 CTAGAGTGCCCAACTCAATGCTGGCAACTAGTAACAAGGGTTGCGCTCGTTGCGGGACTT 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1154 CTAGAGTGCCCAACTCAATGCTGGCAACTAGTAACAAGGGTTGCGCTCGTTGCGGGACTT 1095
Qy 361 AACCCAACATCTCACGACACGAGCTGACGACGACCATGCACCACCTGTCATTGCGTCCCC 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1094 AACCCAACATCTCACGACACGAGCTGACGACGACCATGCACCACCTGTCATTGCGTCCCC 1035
Qy 421 GAAGGGAACGCCTTATCTCTAAGGTTAGCGCAAGATGTCAAGACCTGGTAAGGTTCTTCG 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 1034 GAAGGGAACGCCTTATCTCTAAGGTTAGCGCAAGATGTCAAGACCTGGTAAGGTTCTTCG 975
Qy 481 CGTAGCTTCGAATTAAACCACATGCTCCACCGCTTGTGCGGGCCCCCGTCAATTCCTTTG 540
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 974 CGTAGCTTCGAATTAAACCACATGCTCCACCGCTTGTGCGGGCCCCCGTCAATTCCTTTG 915
Qy 541 AGTTTCAACCTTGCGGTCGTACTCCCCAGGCGGAGTGCTTAATGCGTTAGCTCCGGCACT 600
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 914 AGTTTCAACCTTGCGGTCGTACTCCCCAGGCGGAGTGCTTAATGCGTTAGCTCCGGCACT 855
Qy 601 GAAGGGCGGAAACCCTCCAACACCTAGCACTCATCGTTTACGGCATGGACTACCAGGGTA 660
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 854 GAAGGGCGGAAACCCTCCAACACCTAGCACTCATCGTTTACGGCATGGACTACCAGGGTA 795
Qy 661 TCTAATCCTGTTCGCTACCCATGCTTTCGAGCCTCAGCGTCAGTTGCAGACCAGACAGCC 720
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 794 TCTAATCCTGTTCGCTACCCATGCTTTCGAGCCTCAGCGTCAGTTGCAGACCAGACAGCC 735
Qy 721 GCCTTCGCCACTGGTGTTCTTCCATATATCTACGCATTCCACCGCTACACATGGAGTTCC 780
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 734 GCCTTCGCCACTGGTGTTCTTCCATATATCTACGCATTCCACCGCTACACATGGAGTTCC 675
Qy 781 ACTGTCCTCTTCTGCACTCAAGTCGCCCGGTTTCCGATGCACTTCTTCGGTTAAGCCGAA 840
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 674 ACTGTCCTCTTCTGCACTCAAGTCGCCCGGTTTCCGATGCACTTCTTCGGTTAAGCCGAA 615
Qy 841 GGCTTTCACATCAGACCTAAGCAACCGCCTGCGCTCGCTTTACGCCCAATAAATCCGGAT 900
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 614 GGCTTTCACATCAGACCTAAGCAACCGCCTGCGCTCGCTTTACGCCCAATAAATCCGGAT 555
Qy 901 AACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGTGACTTTCTGG 960
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 554 AACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGTGACTTTCTGG 495
Qy 961 TTGGATACCGTCACTGCGTGAACAGTTACTCTCACGCACGTTCTTCTCCAACAACAGAGC 1020
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 494 TTGGATACCGTCACTGCGTGAACAGTTACTCTCACGCACGTTCTTCTCCAACAACAGAGC 435
Qy 1021 TTTACGAGCCGAAACCCTTCTTCACTCACGCGGTGTTGCTCCATCAGGCTTGCGCCCATT 1080
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 434 TTTACGAGCCGAAACCCTTCTTCACTCACGCGGTGTTGCTCCATCAGGCTTGCGCCCATT 375
Qy 1081 GTGGAAGATTCCCTACTGCTGCCTCCCGTAGGAGTATGGACCGTGTCTCAGTTCCATTGT 1140
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 374 GTGGAAGATTCCCTACTGCTGCCTCCCGTAGGAGTATGGACCGTGTCTCAGTTCCATTGT 315
Qy 1141 GGCCGATCAGTCTCTCAACTCGGCTATGCATCATCGCCTTGGTAAGCCGTTACCTTACCA 1200
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 314 GGCCGATCAGTCTCTCAACTCGGCTATGCATCATCGCCTTGGTAAGCCGTTACCTTACCA 255
Qy 1201 ACTAGCTAATGCACCGCAGGTCCATCCCAGAGTGATAGCCAAAGCCATCTTTCAAACAAA 1260
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 254 ACTAGCTAATGCACCGCAGGTCCATCCCAGAGTGATAGCCAAAGCCATCTTTCAAACAAA 195
Qy 1261 AGCCATGCGGCTTTTGTTGTTATGCGGTATTAGCATCTGTTTCCAAATGTTATCCCCCGC 1320
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 194 AGCCATGCGGCTTTTGTTGTTATGCGGTATTAGCATCTGTTTCCAAATGTTATCCCCCGC 135
Qy 1321 TCCGGGGCAGGTTACCTACGTGTTACTCACCCGTCCGCCACTCACTGGTGATCCATCGTC 1380
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Db 134 TCCGGGGCAGGTTACCTACGTGTTACTCACCCGTCCGCCACTCACTGGTGATCCATCGTC 75
Qy 1381 AATCAGGTGCAAGCACCATCAATCAGTTGGGCCAGTGCGTACGACTGC 1428
||||||||||||||||||||||||||||||||||||||||||||||||
Db 74 AATCAGGTGCAAGCACCATCAATCAGTTGGGCCAGTGCGTACGACTGC 27
Conclusion
13) No claims are allowed.
14) Applicants’ amendment necessitated the new ground(s) of rejection presented in this Office action. THIS ACTION IS MADE FINAL. Applicants are reminded of the extension of time policy as set forth in 37 C.F.R 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 C.F.R 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Correspondence
15) Any inquiry concerning this communication or earlier communications from the Examiner should be directed to S. Devi, Ph.D., whose telephone number is (571) 272-0854. A message may be left on the Examiner’s voice mail system. The Examiner is on a flexible work schedule, however she can normally be reached Monday to Friday from 8.00 a.m. to 4.00 p.m. (EST). If attempts to reach the Examiner by telephone are unsuccessful, the Supervisory Examiner, Jeffrey Stucker, can be reached at (571) 272-0911. The fax phone number for the organization where this application or proceeding is assigned (571) 273-8300.
16) Information regarding the status of an application may be obtained from Patent Center. Status information for unpublished applications is available through Patent Center or Private PAIR to authorized users only. Should you have questions about access to Patent Center or the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, Applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
/S. DEVI/
S. Devi, Ph.D.Primary Examiner
Art Unit 1645
October, 2026